VITASPRING BIOMEDICAL CO., LTD.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $2.0M | $3.6M | $107.2K |
| FY2023 | $3.2M | $765.9K | $29.7K |
| FY2024 | $3.5M | $137.3K | $0 |
| FY2025 | $4.0M | $14.4K | $0 |
| FY2026 | $4.4M | $14.7K | $2.1K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $2.0M | $3.6M | $107.2K |
| FY2023 | $3.2M | $765.9K | $29.7K |
| FY2024 | $3.5M | $137.3K | $0 |
| FY2025 | $4.0M | $14.4K | $0 |
| FY2026 | $4.4M | $14.7K | $2.1K |